English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1451]
News [3002]
Articles [135]
Editorials [5]
Conferences [162]
elearning [6]
Mayo Clinic receives large federal grant to fund clinical test of innovative triple-negative breast cancer vaccine
Mayo Clinic receives large federal grant to fund clinical test of innovative triple-negative breast cancer vaccine
Clear images produced of enzyme that plays key roles in aging and cancer
Clear images produced of enzyme that plays key roles in aging and cancer
Annual versus biennial mammography and breast tumour prognostic characteristics
Annual versus biennial mammography and breast tumour prognostic characteristics
Disparities in breast cancer persist across all subtypes and stages
Disparities in breast cancer persist across all subtypes and stages
Researchers show that genetic background regulates tumour differences
Researchers show that genetic background regulates tumour differences
Gene therapy doubles survival in recurrent glioblastoma
Gene therapy doubles survival in recurrent glioblastoma
Intracellular receptor signalling sustains cancer cells that have detached from the surrounding tissue
Intracellular receptor signalling sustains cancer cells that have detached from the surrounding tissue
ECC 2015: Discovery of significant genetic differences between breast cancers that relapse and those that do not will lead to better treatment
ECC 2015: Discovery of significant genetic differences between breast cancers that relapse and those that do not...
Method of immunotherapy delivery lowers pain in children with high-risk neuroblastoma
Method of immunotherapy delivery lowers pain in children with high-risk neuroblastoma
Small protein engineered to target PD-L1 is more potent than anti-PD-L1 antibody immunotherapeutic
Small protein engineered to target PD-L1 is more potent than anti-PD-L1 antibody immunotherapeutic
<1…234235236237238…301>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top